期刊文献+

骨关节炎病理进程相关机制的研究进展 被引量:2

原文传递
导出
摘要 骨关节炎(OA)的发病机制比较复杂,其发生与年龄、性别、遗传、肥胖、创伤有关。目前对于OA的治疗还没有很好的措施,其发生后病情发展的机制研究成为本领域的研究重点。目前已发现与OA病情发展相关的细胞因子、信号通路、蛋白酶类的作用机制的研究均处于初级阶段,且以各种作用机制指导的临床治疗措施效果欠佳。为进一步明确OA发展的相关病理机制,现对近几年来国内外本领域的相关研究作一综述,为探索更加有效的治疗方法提供新的理论依据。
出处 《华西医学》 CAS 2012年第11期1741-1744,共4页 West China Medical Journal
  • 相关文献

参考文献47

  • 1李宁华,薛庆云,张毅,张耀南,王晓宾,申剑,赵力连.中国六城市中老年人群X线膝骨关节炎流行病学分析[J].实用医学杂志,2008,24(16):2887-2888. 被引量:92
  • 2Marks PH, Donaldson ML. Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee[J]. Arthroscopy, 2005, 21(11): 1342-1347.
  • 3林木南,刘献祥.骨性关节炎中细胞因子的协同效应[J].福建中医学院学报,2006,16(2):69-70. 被引量:57
  • 4Arend WP. Interleukin-1 receptor antaganist[J]. Adv Immunol, 2007, 54(16): 721-723.
  • 5Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis[J]. Arthritis Res Ther, 2008, 10(Suppl 2): 2.
  • 6Mix KS, Mengshol JA, Benbow U, et al. A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines[J]. Arthritis Rheum, 2001, 44(5): 1096-1104.
  • 7Daheshia M, Yao JQ. The interleukin Ibeta pathway in the pathogenesis of osteoarthritis[J]. Rheum, 2008, 35(12): 2306-2312.
  • 8Wang X, Li F, Fan C, et al. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alteration in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes[J]. Int J Mol Med, 2011, 27(4): 583-589.
  • 9Im H J, Pacione C, Chubinskaya S, et al. Inhibitory effects of fibronectin fragment and interleukin-1β-stimulated matrix metal oproteinase-13 expression in human chondrocytes[J]. J Biol Chem, 2003, 278(28): 25386-25394.
  • 10Ghivizzani SC, Kang R, Georgescu HI, et al. Constitutive intra- articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis[J]. J Immunol, 1997, 159(7): 3604-3612.

二级参考文献180

共引文献229

同被引文献60

  • 1张文军,李荣山.p38丝裂原活化蛋白激酶通路及其研究进展[J].医学综述,2007,13(9):663-665. 被引量:16
  • 2Felson DT. Clinical practice. Osteoarthritis of the knee[J].{H}New England Journal of Medicine,2006,(08):841-848.
  • 3Abramson SB,Yazici Y. Biologics in development for rheumatoid arthritis:relevance to osteoarthritis[J].{H}Advanced Drug Delivery Reviews,2006,(02):212-225.
  • 4Hashimoto S,Setareh M,Ochs RL. Fas/Fas ligand expression and induction of apoptosis in chondrocytes[J].{H}ARTHRITIS AND RHEUMATISM,1997,(10):1749-1755.
  • 5Kim SJ,Ju JW,Oh CD. ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis in chondrocytes in association with p53,caspase-3 and differentiation status[J].{H}Journal of Biological Chemistry,2002,(02):1332-1339.
  • 6Wei L,Sun XJ,Wang Z. CD95-induced osteoarthritis chondrocyte apoptosis and necrosis:dependency on p38 mitogen-activated protein kinase[J].{H}Arthritis Research & Therapy,2006,(02):R37.
  • 7Menqshol JA,Vincenti MP,Coon CI. Interleukin -1 induction of col agenase 3(matrix metal oproteinase 13) gene expression in chondrocytes requires p38,c-Jun N -terminal kinase,and nuclear factor kappaB:differential regulation of col agenase 1 and col agenase3[J].{H}ARTHRITIS AND RHEUMATISM,2000,(04):801-811.
  • 8Papadakis KA,Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease[J].{H}Annual Review of Medicine,2000.289-298.
  • 9Morazzani M,de Carvalho DD,Kovacic H. Monolayer versus aggregate balance in survival process for EGF-induced apoptosis in A431 carcinoma cells:Implication of ROS-p38 MAPK-integrin alpha2betal pathway[J].{H}International Journal of Cancer,2004,(06):788-799.
  • 10Han J,Lee JD,Bibbs L. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells[J].{H}SCIENCE,1994,(5173):808-811.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部